Dalton, Greiner, Hartman, Maher & Co’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-38,400
Closed -$227K 157
2019
Q3
$227K Buy
+38,400
New +$244K 0.02% 188

Other funds holding ASPN

Dalton, Greiner, Hartman, Maher & Co's ASPN Position: Q4 2019 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Aspen Aerogels (ASPN) in Q4 2019, closing a stake of 38,400 shares — an estimated $227K sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in ASPN in Q3 2019 and held it in 1 quarter. The position peaked at $227K in Q3 2019. 48 funds tracked by Wall St. Rank hold ASPN as of Q4 2019.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Aspen Aerogels position as of Q4 2019 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 38,400 Aspen Aerogels shares in Q4 2019, an estimated $227K.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Aspen Aerogels in Q3 2019 and held it in 1 quarter.
  • Dalton, Greiner, Hartman, Maher & Co's Aspen Aerogels position peaked at $227K in Q3 2019.
  • 48 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2019.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q4 2019, filed 15 Jan 2020.